Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ocular Therapeutix granted inducement equity awards to eight newly hired non-executive employees, consisting of options to purchase 53,975 shares and RSUs for 17,450 shares. The options have a ten-year term with a four-year vesting schedule and an exercise price of $8.40 per share, equal to the closing price on the grant date.
Key figures
- Rsus granted
- 17450
- Exercise price
- 8.4
- Options granted
- 53975
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.